- From: Kashyap, Vipul <VKASHYAP1@PARTNERS.ORG>
- Date: Fri, 9 Nov 2007 09:18:47 -0500
- To: "Andersson, Bo H" <Bo.H.Andersson@astrazeneca.com>
- Cc: <public-hcls-dse@w3.org>, "Stanley Huff" <Stan.Huff@intermountainmail.org>, "Oniki, Tom (GE Healthcare, consultant)" <Tom.Oniki@ge.com>, "Jonathan Rees" <jar@creativecommons.org>, "Alan Ruttenberg" <alanruttenberg@gmail.com>
> Good to know we have very similar thoughts. I do think it's > important we revisit the objectives regularly, otherwise we > might miss the bigger picture of secondary use. Absolutely, I could not agree more. And I would highly encourage you and Kerstin to raise these type of issues whenever you find that we are straying > I'm not arguing for more or broader use cases, actually the > present one is very relevant, but for the importance to keep > the long term objective in mind when we develop the use case. Great! > I hope the discussions went well yesterday, had to leave due > to the phone line (the sound quality was lousy). Yes, the minutes of some of the results of the brainstorming sessions will be posted on the wiki site. ---Vipul The information transmitted in this electronic communication is intended only for the person or entity to whom it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of or taking of any action in reliance upon this information by persons or entities other than the intended recipient is prohibited. If you received this information in error, please contact the Compliance HelpLine at 800-856-1983 and properly dispose of this information.
Received on Friday, 9 November 2007 14:19:05 UTC